Pharmacodiagnostics and targeted therapies - a rational approach for individualizing medical anticancer therapy in breast cancer.
about
EGFR/HER-targeted therapeutics in ovarian cancerUtilizing the molecular gateway: the path to personalized cancer management.Pharmacists' role in targeted cancer therapy in Australia and implications for pharmacy educationPotentiation of the growth inhibition activity of 2-({4-[4-(acridin-9-ylamino)phenylthio]phenyl}(2-hydroxyethyl)amino)ethan-1-ol (CK0402) by Herceptin in SKBR-3 human breast cancer cellsHER2/NEU GENE EXPRESSION PRODUCTS EVALUATED WITH SUPERPARAMAGNETIC, GENETICALLY ENGINEERED ANTIBODIESPegylated liposomal doxorubicin and gemcitabine in the front-line treatment of recurrent/metastatic breast cancer: a multicentre phase II study.Are we approaching the post-blockbuster era? Pharmacodiagnostics and rational drug development.(18)F-FDG PET/CT of advanced gastric carcinoma and association of HER2 expression with standardized uptake value.Development of optimal medium for production of commercially important monoclonal antibody 520C9 by hybridoma cell.
P2860
Q26863231-8BE06C09-8456-425B-BFA0-8512E7DF94B1Q30371443-7A4B90DF-BBC6-4975-8A9E-A4E7B7F5B2F7Q34377984-4CA6E157-EDE9-4F99-A1DD-FCED8A629E6DQ36244099-8B20EF81-EB67-4CED-B7B5-3437CA4F3459Q36505059-C8868053-CCD7-4B71-A5C2-50B7333C1D72Q36740641-3B0DE35B-F5C6-4DEA-8746-FDB11581F90EQ37322436-E6C9FB55-C423-4EE1-AC90-B905FC1D1DA9Q41835781-D355F476-21D7-4803-8838-128FCBB20129Q43109224-184E1E5B-E0C7-4471-B620-106CD7D0FB09
P2860
Pharmacodiagnostics and targeted therapies - a rational approach for individualizing medical anticancer therapy in breast cancer.
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Pharmacodiagnostics and target ...... ncer therapy in breast cancer.
@ast
Pharmacodiagnostics and target ...... ncer therapy in breast cancer.
@en
Pharmacodiagnostics and target ...... ncer therapy in breast cancer.
@nl
type
label
Pharmacodiagnostics and target ...... ncer therapy in breast cancer.
@ast
Pharmacodiagnostics and target ...... ncer therapy in breast cancer.
@en
Pharmacodiagnostics and target ...... ncer therapy in breast cancer.
@nl
prefLabel
Pharmacodiagnostics and target ...... ncer therapy in breast cancer.
@ast
Pharmacodiagnostics and target ...... ncer therapy in breast cancer.
@en
Pharmacodiagnostics and target ...... ncer therapy in breast cancer.
@nl
P1433
P1476
Pharmacodiagnostics and target ...... ncer therapy in breast cancer.
@en
P2093
Jan Trøst Jørgensen
Kirsten Vang Nielsen
P304
P356
10.1634/THEONCOLOGIST.12-4-397
P577
2007-04-01T00:00:00Z